This Washington Post article raises some interesting questions about the role of pharmaceuticals in sexuality:
FDA considers endorsement of drug that some call a Viagra for women
A German pharmaceutical giant wants to sell a drug with the decidedly unsexy name “flibanserin,” which has shown prowess for sparking a woman’s sexual desire by fiddling with her brain chemicals.
Some issues under discussion are the potential for abuse, the ability of a drug company to create diseases and then medicines to fix them, and the concern that waning sexual desire is a natural process that we should not interfere with.
Ack, really? You mean like wrinkles, arthritis, or dementia?
If it works, think of all those individuals who will be quietly humming and smiling as they go about their daily business, basking in the glow of renewed passion, closeness, and intimacy. We’ll be way too relaxed to worry about whether we have just allowed a pharmaceutical company to dictate to us what “normal” is and to sell us a medicine to make sure we meet their criteria.